Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF Primary Prophylaxis for Neutropenia in Advanced Colorectal Cancer on Biweekly Chemotherapy
ChiCTR2600130850Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of pegfilgrastim in colorectal cancer (CRC) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Incidence of grade ≥3 ANC reduction in the first and subsequent cycles. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
pegfilgrastim
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2600130850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130850.